Mirum Pharmaceuticals Inc (+1, MIRM US, September 14th)
Patrick Heron (Director since Nov. 2018) purchased $257,000 worth of stock on September 12th at $30.44. The purchase is indirect Frazier Life Sciences Healthcare, a private equity and venture capital firm where Heron has been a GP since 1999. Heron/Frazier Life, spent $3.9 million two weeks ago on a secondary offering at $26.25, and it is interesting to see them add at a higher price, in their first open market purchase in these shares.
The company named a new CFO, Eric Bjerkholt, in September and he made his first purchase, spending $300,000. He was formerly the CFO at Chinook Therapeutics. This is the first insider buying since November 2021 when the stock was at $14.
We are ranking the stock +1.
If you want to have Stock of the Week with insider buying stocks information and analysis in your email, don’t forget to subscribe!
Follow us on LinkedIn and Twitter
Check our Signals Performance and if you want to know more about this Signals Service, please, email us at sales_admin@smartinsider.com or fill in the Contact Us form here.
